# Allarity Therapeutics, Inc.: Form 10-K for the period ended Dec 31, 2024

- Company: [Allarity Therapeutics, Inc.](/companies/allr.md) (CIK 1860657)
- Form: 10-K
- Filed: 2025-03-31
- Accepted by EDGAR: Mar 31, 2025, 16:16 ET
- Period: 2024-12-31
- Accession: 0001437749-25-010198
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1860657/000143774925010198/allr20241231_10k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1860657/000143774925010198/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $6.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −$27.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-01-01 to 2024-12-31 | $653.0k | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | −$381.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | −$24.5m | us-gaap:NetIncomeLoss |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | −$15.65 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | −$17.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | $298.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-12-31 | $19.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $22.3m | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $22.6m | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $10.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $10.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2024-12-31 | $11.8m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1860657/000143774925010198/allr20241231_10k.htm

Filed Mar 31, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-010198. Last ingested by Listed: Nov 2, 2026, 08:01 ET. No prices; not investment advice.